Your browser doesn't support javascript.
loading
Cancer risk and use of protease inhibitor or nonnucleoside reverse transcriptase inhibitor-based combination antiretroviral therapy: the D: A: D study.
Bruyand, Mathias; Ryom, Lene; Shepherd, Leah; Fatkenheuer, Gerd; Grulich, Andrew; Reiss, Peter; de Wit, Stéphane; D Arminio Monforte, Antonella; Furrer, Hansjakob; Pradier, Christian; Lundgren, Jens; Sabin, Caroline.
  • Bruyand M; *INSERM, ISPED, Centre Inserm U897-Epidemiologie-Biostatistique, Bordeaux, France; †Copenhagen HIV Programme, Department of Infectious Diseases and Rheumatology, Section 8632, Finsencenteret, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark; ‡Research Department of Infection and Population Health, UCL, London, United Kingdom; §First Department of Internal Medicine, University Hospital of Cologne, Köln, Germany; ‖German Center for Infection research (DZIF); ¶HIV Epidemiology and Prev
J Acquir Immune Defic Syndr ; 68(5): 568-77, 2015 Apr 15.
Article en En | MEDLINE | ID: mdl-25763785
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Proteasas / Infecciones por VIH / Inhibidores de la Transcriptasa Inversa / Terapia Antirretroviral Altamente Activa / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Inhibidores de Proteasas / Infecciones por VIH / Inhibidores de la Transcriptasa Inversa / Terapia Antirretroviral Altamente Activa / Neoplasias Tipo de estudio: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Female / Humans / Male / Middle aged Idioma: En Año: 2015 Tipo del documento: Article